Expression and clinical significance of HER-2 in gastric cancer and metastastic lymph nodes
REN Tao-Wen,WU Jing,ZHOU Yong-Ning,ZHANG Zhi-Yi,HAO Tian-Jun,WANG Juan-Xia,ZOU Shao-Jing,CHEN Zhao-Feng,HUANG Shan-Shan,ZHANG Li-Hua,ZHAO Yue
2009-01-01
Abstract:AIM:To investigate the expression of HER-2 in gastric cancer,Para-Cancerous Tissue and metastastic lymph nodes,explore its role and significance of the clinicopathology as well as prognosis,its correlation with lymph node metastasis and primary focus. METHODS:To examine expression of HER-2 on tissue microarray containing gastric normal mucosa (n=32),Para-Cancerous Tissue(n=54),metastastic lymph nodes (n=41),and gastric cancer (n=189) by immunohistochemistry. RESULTS:The positive rates for HER-2 of the gastric cancer paracancer and control were 68.8%,25.9% and 12.5% respectively,with significant difference among the three case groups(P<0.05). In gastric cancer tissues,The positive rates of HER-2 protein were significantly associated with lymph node metastasis,depth of invasion,Lauren type,the degree of differentiation (P<0.05),and not associated with sex,age,size of tumor(P>0.05). The positive rates for HER-2 of the 41 gastric cancer and 41 metastastic lymph nodes were significantly different(P<0.05). In metastastic lymph nodes,The positive rates for HER-2 is higher.Used Kaplan-Meier survival analysis,The survival time of patients with negative HER-2 was higher than those of patients with positive HER-2(P<0.05),COX regression analys is showed that HER-2 expression was an independent prognostic factor of gastric cancer. CONCLUSION:The higher-expression of HER-2 is involved in occurring and development,invasion,metastasis of gastric cancer and a advanced incidents of gastric cancer. metastastic lymph nodes is heterogeneity that compared with primary tumors. HER-2 is a useful marker for predicting the outcome for patients with gastric cancer,and it is an independent prognostic indicator.